PT Kalbe Farma Tbk.'s latest marketcap:
As of 07/05/2025, PT Kalbe Farma Tbk.'s market capitalization has reached $4.27 B. According to our data, PT Kalbe Farma Tbk. is the 3736th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 4.27 B |
| Revenue (ttm) | 2 B |
| Net Income (ttm) | 202.9 M |
| Shares Out | 0 |
| EPS (ttm) | 0 |
| Forward PE | 18.90 |
| Ex-Dividend Date | 06/04/2025 |
| Earnings Date | 08/01/2025 |
PT Kalbe Farma Tbk.'s yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | $4.27 B | 8.99% | 3736 |
| 12/30/2024 | $3.89 B | -19.49% | 45432 |
| 12/29/2023 | $4.83 B | -22.39% | 43802 |
| 12/30/2022 | $6.23 B | 17.3% | 42137 |
| 12/30/2021 | $5.31 B | 7.29% | 40266 |
| 12/30/2020 | $4.95 B | -9.36% | 37233 |
| 12/30/2019 | $5.46 B | 11.24% | 34691 |
| 12/28/2018 | $4.91 B | -16.05% | 33421 |
| 12/29/2017 | $5.84 B | 10.88% | 32009 |
| 12/30/2016 | $5.27 B | 17.42% | 30081 |
Company Profile
About PT Kalbe Farma Tbk.
PT Kalbe Farma Tbk., along with its subsidiaries, is a leading pharmaceutical company in Indonesia. Established in 1966 and headquartered in Jakarta, the company specializes in developing, manufacturing, and trading a wide range of healthcare products.
Business Divisions
The company operates through four key divisions:
- Prescription Pharmaceuticals – Focused on ethical and prescription medicines.
- Consumer Health – Offers over-the-counter healthcare products.
- Nutritionals – Provides nutritional supplements and health foods.
- Distribution and Logistics – Manages supply chain and distribution services.
Product & Service Offerings
Kalbe Farma delivers a diverse portfolio, including:
- Prescription and consumer health products.
- Nutritional supplements and biopharmaceuticals.
- Medical devices and animal health products.
- Health services through Mitrasana Clinics.
- Distribution of medical equipment, cosmetics, and raw materials.
- Advertising and health screening services.
With a strong presence in Indonesia, Kalbe Farma continues to expand its international business and e-health initiatives, reinforcing its commitment to improving healthcare accessibility.
Frequently Asked Questions
-
What is PT Kalbe Farma Tbk.'s (OTC-PTKFF) current market cap?As of 07/05/2025, PT Kalbe Farma Tbk. (including the parent company, if applicable) has an estimated market capitalization of $4.27 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does PT Kalbe Farma Tbk. (OTC-PTKFF) rank globally by market cap?PT Kalbe Farma Tbk. global market capitalization ranking is approximately 3736 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.